%PDF- %PDF-
Mini Shell

Mini Shell

Direktori : /var/www/html/digiprint/public/site/trwzrk/cache/
Upload File :
Create Path :
Current File : /var/www/html/digiprint/public/site/trwzrk/cache/ba732df070ce011409e18f8c798190b3

a:5:{s:8:"template";s:7286:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1" name="viewport"/>
<title>{{ keyword }}</title>
<link href="//fonts.googleapis.com/css?family=Lato%3A300%2C400%7CMerriweather%3A400%2C700&amp;ver=5.4" id="siteorigin-google-web-fonts-css" media="all" rel="stylesheet" type="text/css"/>
<style rel="stylesheet" type="text/css">html{font-family:sans-serif;-webkit-text-size-adjust:100%;-ms-text-size-adjust:100%}body{margin:0}footer,header,nav{display:block}a{background-color:transparent}svg:not(:root){overflow:hidden}button{color:inherit;font:inherit;margin:0}button{overflow:visible}button{text-transform:none}button{-webkit-appearance:button;cursor:pointer}button::-moz-focus-inner{border:0;padding:0}html{font-size:93.75%}body,button{color:#626262;font-family:Merriweather,serif;font-size:15px;font-size:1em;-webkit-font-smoothing:subpixel-antialiased;-moz-osx-font-smoothing:auto;font-weight:400;line-height:1.8666}.site-content{-ms-word-wrap:break-word;word-wrap:break-word}html{box-sizing:border-box}*,:after,:before{box-sizing:inherit}body{background:#fff}ul{margin:0 0 2.25em 2.4em;padding:0}ul li{padding-bottom:.2em}ul{list-style:disc}button{background:#fff;border:2px solid;border-color:#ebebeb;border-radius:0;color:#2d2d2d;font-family:Lato,sans-serif;font-size:13.8656px;font-size:.8666rem;line-height:1;letter-spacing:1.5px;outline-style:none;padding:1em 1.923em;transition:.3s;text-decoration:none;text-transform:uppercase}button:hover{background:#fff;border-color:#24c48a;color:#24c48a}button:active,button:focus{border-color:#24c48a;color:#24c48a}a{color:#24c48a;text-decoration:none}a:focus,a:hover{color:#00a76a}a:active,a:hover{outline:0}.main-navigation{align-items:center;display:flex;line-height:1}.main-navigation:after{clear:both;content:"";display:table}.main-navigation>div{display:inline-block}.main-navigation>div ul{list-style:none;margin:0;padding-left:0}.main-navigation>div li{float:left;padding:0 45px 0 0;position:relative}.main-navigation>div li:last-child{padding-right:0}.main-navigation>div li a{text-transform:uppercase;color:#626262;font-family:Lato,sans-serif;font-size:.8rem;letter-spacing:1px;padding:15px;margin:-15px}.main-navigation>div li:hover>a{color:#2d2d2d}.main-navigation>div a{display:block;text-decoration:none}.main-navigation>div ul{display:none}.menu-toggle{display:block;border:0;background:0 0;line-height:60px;outline:0;padding:0}.menu-toggle .svg-icon-menu{vertical-align:middle;width:22px}.menu-toggle .svg-icon-menu path{fill:#626262}#mobile-navigation{left:0;position:absolute;text-align:left;top:61px;width:100%;z-index:10}.site-content:after:after,.site-content:before:after,.site-footer:after:after,.site-footer:before:after,.site-header:after:after,.site-header:before:after{clear:both;content:"";display:table}.site-content:after,.site-footer:after,.site-header:after{clear:both}.container{margin:0 auto;max-width:1190px;padding:0 25px;position:relative;width:100%}@media (max-width:480px){.container{padding:0 15px}}.site-content:after{clear:both;content:"";display:table}#masthead{border-bottom:1px solid #ebebeb;margin-bottom:80px}.header-design-2 #masthead{border-bottom:none}#masthead .sticky-bar{background:#fff;position:relative;z-index:101}#masthead .sticky-bar:after{clear:both;content:"";display:table}.sticky-menu:not(.sticky-bar-out) #masthead .sticky-bar{position:relative;top:auto}#masthead .top-bar{background:#fff;border-bottom:1px solid #ebebeb;position:relative;z-index:9999}#masthead .top-bar:after{clear:both;content:"";display:table}.header-design-2 #masthead .top-bar{border-top:1px solid #ebebeb}#masthead .top-bar>.container{align-items:center;display:flex;height:60px;justify-content:space-between}#masthead .site-branding{padding:60px 0;text-align:center}#masthead .site-branding a{display:inline-block}#colophon{clear:both;margin-top:80px;width:100%}#colophon .site-info{border-top:1px solid #ebebeb;color:#626262;font-size:13.8656px;font-size:.8666rem;padding:45px 0;text-align:center}@media (max-width:480px){#colophon .site-info{word-break:break-all}}@font-face{font-family:Lato;font-style:normal;font-weight:300;src:local('Lato Light'),local('Lato-Light'),url(http://fonts.gstatic.com/s/lato/v16/S6u9w4BMUTPHh7USSwiPHA.ttf) format('truetype')}@font-face{font-family:Lato;font-style:normal;font-weight:400;src:local('Lato Regular'),local('Lato-Regular'),url(http://fonts.gstatic.com/s/lato/v16/S6uyw4BMUTPHjx4wWw.ttf) format('truetype')}@font-face{font-family:Merriweather;font-style:normal;font-weight:400;src:local('Merriweather Regular'),local('Merriweather-Regular'),url(http://fonts.gstatic.com/s/merriweather/v21/u-440qyriQwlOrhSvowK_l5-fCZJ.ttf) format('truetype')}@font-face{font-family:Merriweather;font-style:normal;font-weight:700;src:local('Merriweather Bold'),local('Merriweather-Bold'),url(http://fonts.gstatic.com/s/merriweather/v21/u-4n0qyriQwlOrhSvowK_l52xwNZWMf_.ttf) format('truetype')} </style>
 </head>
<body class="cookies-not-set css3-animations hfeed header-design-2 no-js page-layout-default page-layout-hide-masthead page-layout-hide-footer-widgets sticky-menu sidebar wc-columns-3">
<div class="hfeed site" id="page">
<header class="site-header" id="masthead">
<div class="container">
<div class="site-branding">
<a href="#" rel="home">
{{ keyword }}</a> </div>
</div>
<div class="top-bar sticky-bar sticky-menu">
<div class="container">
<nav class="main-navigation" id="site-navigation" role="navigation">
<button aria-controls="primary-menu" aria-expanded="false" class="menu-toggle" id="mobile-menu-button"> <svg class="svg-icon-menu" height="32" version="1.1" viewbox="0 0 27 32" width="27" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
<path d="M27.429 24v2.286q0 0.464-0.339 0.804t-0.804 0.339h-25.143q-0.464 0-0.804-0.339t-0.339-0.804v-2.286q0-0.464 0.339-0.804t0.804-0.339h25.143q0.464 0 0.804 0.339t0.339 0.804zM27.429 14.857v2.286q0 0.464-0.339 0.804t-0.804 0.339h-25.143q-0.464 0-0.804-0.339t-0.339-0.804v-2.286q0-0.464 0.339-0.804t0.804-0.339h25.143q0.464 0 0.804 0.339t0.339 0.804zM27.429 5.714v2.286q0 0.464-0.339 0.804t-0.804 0.339h-25.143q-0.464 0-0.804-0.339t-0.339-0.804v-2.286q0-0.464 0.339-0.804t0.804-0.339h25.143q0.464 0 0.804 0.339t0.339 0.804z"></path>
</svg>
</button>
<div class="menu-menu-1-container"><ul class="menu" id="primary-menu"><li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-home menu-item-20" id="menu-item-20"><a href="#">About</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-165" id="menu-item-165"><a href="#">Blog</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-24" id="menu-item-24"><a href="#">FAQ</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-22" id="menu-item-22"><a href="#">Contacts</a></li>
</ul></div> </nav>
<div id="mobile-navigation"></div>
</div>
</div>
</header>
<div class="site-content" id="content">
<div class="container">
{{ text }}
<br>
{{ links }}
</div>
</div>
<footer class="site-footer " id="colophon">
<div class="container">
</div>
<div class="site-info">
<div class="container">
{{ keyword }} 2021</div>
</div>
</footer>
</div>
</body>
</html>";s:4:"text";s:15340:"At Vertex Pharmaceuticals, we recognize Rare Disease Week and Rare Disease Day® at the end of February every year, but our commitment to patients is o… Discover More Vertex Foundation. That is a particularly disappointing performance, especially considering the … View the Indication, Important Safety and Prescribing Information. Vertex Pharmaceuticals Inc (NASDAQ:VRTX) is a biopharmaceutical company. Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. 26, 2021– Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that it will advance the selective NaV1.8 inhibitor, VX-548, into Phase 2 clinical development with clinical trials in patients with both visceral and non-visceral types of acute pain. The top 10 competitors average 24,474. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) investors will be delighted, with the company turning in some strong numbers with its … Fri, May 7, 8:24 AM, Zacks Moderna (MRNA) Beats on Q1 Earnings, Ups Vaccine Sales View Edit Profile. Vertex Pharmaceuticals Is a Biotech Play With No Coronavirus Exposure By Louis Navellier and the InvestorPlace Research Staff, Editor, Growth Investor Jun 2, 2020 (RTTNews) - Vertex Pharmaceuticals Inc. (VRTX) reported earnings for its first quarter that increased from the same period last year. Vertex Pharmaceuticals is a biopharmaceutical company that currently produces Cystic Fibrosis treatments. In … Current and historical p/e ratio for Vertex Pharmaceuticals (VRTX) from 2006 to 2021. This … A list of all funds holding Vertex Pharmaceuticals. In the past year, Vertex Pharmaceuticals' (NASDAQ: VRTX) stock price has fallen by 24%. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Q1 2021 Earnings Call Apr 29, 2021, 5:30 p.m. In the past year, Vertex Pharmaceuticals' (NASDAQ:VRTX) stock price has fallen by 24%. On average, equities analysts predict that Vertex Pharmaceuticals Incorporated will post 9.42 EPS for the current year. Vertex Pharmaceuticals Incorporated receives a strong valuation score of 62 from InvestorsObserver's analysis.Our proprietary scoring system considers the overall health of the company by looking at the stock's price, earnings, and growth rate to determine if it represents a good value. Vertex Pharmaceuticals Will Launch a Clinical Trial of Stem Cell-Derived Beta Cells. Vertex Pharmaceuticals Position Description. Posted: May 24, 2021 Full-Time Job Description. Read more to learn how to profit from this trade. Vertex Pharmaceuticals Inc discovers and develops small-molecule drugs for the treatment of serious diseases. Historical daily share price chart and data for Vertex Pharmaceuticals since 1991 adjusted for splits. Fri, May 7, 8:24 AM, Zacks Moderna (MRNA) Beats on Q1 Earnings, Ups Vaccine Sales View About Vertex Pharmaceuticals . The biotechnology firm has four commercial drugs -- Trikafta, Orkambi, Kalydeco, and Symdeko/Symkevi -- used to treat CF. Vertex Pharmaceuticals Incorporated NASDAQ Updated May 21, 2021 11:20 PM. No grant provided by Vertex is conditioned in any way on the use, The all-time high Vertex Pharmaceuticals stock closing price was 303.10 on July 20, 2020.; The Vertex Pharmaceuticals 52-week high stock price is 306.08, which is 43.4% above the current share price. Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts. Vertex has stopped development of VX-961 after getting a look at phase 1 data. Vertex Pharmaceuticals Inc VRTX Morningstar Rating Rating as of May 21, 2021. Vertex Pharmaceuticals Incorporated is a company in the U.S. stock market and it is a holding in 209 U.S.-traded ETFs. https://bit.ly/30OHX5W #Data #Technology #Engineers #BestPlacetoWork —30+ days ago ET. VX-745, a lead anti-inflammatory candidate, small-molecule inhibitor of mitogen-activated protein kinase (MAPK), is under development by Vertex Pharmaceuticals Inc in association with Kissei Pharmaceutical Co Ltd for the potential treatment of rheumatoid arthritis (RA) [214928]. Vice President and Head of Real World Evidence Center of Excellence . Vertex Pharmaceuticals and CRISPR Therapeutics Amend Collaboration for Development, Manufacturing and Commercialization of CTX001™ in Sickle Cell Disease and Beta Thalassemia - read this article along with other careers information, tips and advice on BioSpace Vertex Pharmaceuticals Incorporated 401k Plan is a defined contribution plan with a 401k feature. Communication regarding transfer requirements, lost certificates and changes of address should be directed to: Computershare Investor Services. It is one of the corporates which submit 10-K filings with the SEC. Vertex Pharmaceuticals (VRTX) came out with quarterly earnings of $2.98 per share, beating the Zacks Consensus Estimate of $2.77 per share. Vertex Pharmaceuticals has a cash-to-debt ratio of 7.15, which ranks in the middle range of the companies in Biotechnology industry. The company report on February 2, 2021 that Vertex Reports Full-Year and Fourth-Quarter 2020 Financial Results.. Get the hottest stocks to trade every day before the market opens 100% free. Vertex and CRISPR Therapeutics to Present New Clinical Data on Investigational CRISPR/Cas9 Gene-Editing Therapy CTX001™ For Severe Hemoglobinopathies at the Annual European Hematology Association Virtual Congress For any catering inquiries, please email FLIK. This is the debt and cash of Vertex Pharmaceuticals over the past years: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) investors will be delighted, with the company turning in some strong numbers with its … Vertex Pharmaceuticals 2018 median employee pay: $232,178 2018 number of employees: 2,500 CEO: Jeffrey Leiden 2018 CEO pay: $18.80 million CEO-to-employee pay ratio: 81.0:1 What do you think? Find the latest Vertex Pharmaceuticals Incorpor (VRTX) stock quote, history, news and other vital information to help you with your stock trading and investing. In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $220.16, marking a +0.45% move from the previous day. 7.  We work with leading researchers, doctors, public health experts and other collaborators who share our vision for transforming the lives of people with serious diseases, their families and society. Vertex Pharmaceuticals Incorporated is engaged in discovering, developing, manufacturing and commercializing medicines for serious diseases. Vertex's product pipeline is focused on viral diseases, BOSTON –(BUSINESS WIRE)–Apr. Ionis's headquarters is in Carlsbad, California, and was founded in 1989. Vertex Pharmaceuticals, Inc. is a global biotechnology company. Vertex Pharmaceuticals is a global biotechnology company that aims to discover, develop and commercialize innovative medicines so people with serious diseases can lead better lives. Vertex Pharmaceuticals: Roller-coaster Pharmaceutical Development Vertex Pharmaceuticals originated as a small pharmaceutical start-up company that was founded in 1989 by Josh Boger. This is a bullish pattern, so the stock could soon experience a breakout. VX-745 was introduce … A free inside look at company reviews and salaries posted anonymously by employees. Holder Amount Position Size ($ in 1000's) As of; BlackRock Inc. 24,244,113: $5,209,816 We believe that the stock price of Vertex Pharmaceuticals (VRTX) is undervalued at current levels of $215. Box 43023 Providence, RI 02940-3023 Telephone: +1(781)-575-2879 Fax: +1(781)-575-3605 Post-Market 1.05 (0.49%) 454 Vertex Pharmaceuticals reviews. Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $215.01, marking a +0.87% move from the previous day. RANK 6. The stock outpaced the S&P 500's daily gain of 0.74%. Barron’s reported on … The Investor Relations website contains information about Vertex Pharmaceuticals's business for stockholders, potential investors, and financial analysts. Vertex Pharmaceuticals Incorporated stock has fallen -19.01% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy.InvestorsObserver’s proprietary ranking system, gives VRTX stock a score of 28 out of a possible 100.. That rank is primarily influenced by a short-term technical score of 2. About VRTX. Come work with Muriel and her innovative team. Vertex Pharmaceuticals fell more than 20% in one session after discontinuing a drug candidate. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their … Vertex Pharmaceuticals Inc (NASDAQ:VRTX) is a biopharmaceutical company. directly at flik_catering@vrtx.com or christopher.fusco@compass-usa.com. Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. Vertex Pharmaceuticals Inc / Ma has 1,100 employees and is ranked 14th among it's top 10 competitors. Job Description Vertex Pharmaceuticals Inc. has established a state-of-the-art GMP manufacturing facility in Boston less than a mile from the Corp... view job Location Boston, MA, United States The Company's strategy is to commercialize its products both independently and in collaboration with major pharmaceutical companies. VERTEX succeeds because we care about our clients and employees—this is the foundation of everything we do. Contacting Vertex's Transfer Agent. Mar 10, 2021 Vertex Gets FDA Fast-Track Designation for VX-880 in Type 1 Diabetes Dow Jones Newswires; Mar 9, 2021 Vertex Pharmaceuticals … Use this tool to find the best option for your patient(s). Future 50 - 2020 Explore this year's ranking of the 50 companies wi... READ MORE view in list. May 7, 2019 5:32 pm 0 The Vertex Pharmaceuticals Data, Technology and Engineering team are hiring! VRTX stock is up a mere 6% off the March 2020 bottom compared to … This change outpaced the S&P 500's 0.68% loss on the day. The employer identification number (EIN) for Vertex Pharmaceuticals Inc / Ma is 043039129. Vertex Pharmaceuticals (VRTX) Outpaces Stock Market Gains: What You Should Know In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $215.01, marking a +0.87% move from the previous day. View VRTX financial statements in full. Vertex Pharmaceuticals, Inc. is a global biotechnology company. Designed to reach early career professionals, the program spans one year, allowing Fellows to collaborate directly with Vertex project teams and make real-world contributions to serious disease areas with unmet patient needs. Vertex Pharmaceuticals Incorporated engages in developing and commercializing therapies for treating cystic fibrosis. VRTX's rank also includes a long-term technical score of 7. Vertex Pharmaceuticals Incorporated [NASDAQ: VRTX] loss -6.23% on the last trading session, reaching $217.33 price per share at the time. Come work with Muriel and her innovative team. EIN for organizations is sometimes also referred to as taxpayer identification number or TIN or simply IRS Number. Vertex Pharmaceuticals had a return on equity of 29.61% and a net margin of 43.06%. We work with leading researchers, doctors, public health experts and other collaborators who share our vision for transforming the lives of people with serious diseases, their families and society. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAFTA for the treatment of patients with … Vertex Foundation: 2020 Impact Overview Michael Parini | January 19, 2021 Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) to acquire Semma Therapeutics to develop curative cell-based treatments for type 1 diabetes. We believe that the stock price of Vertex Pharmaceuticals is undervalued at current levels of $215. Last week’s breakthrough news—that Vertex Pharmaceuticals will launch a clinical trial of VX-880, a stem cell-derived beta cell therapy in type 1 diabetes (T1D)—had its start in 2000.. That’s when JDRF funded Douglas Melton, Ph.D., to make beta cells from stem cells. https://bit.ly/30OHX5W #Data #Technology #Engineers #BestPlacetoWork —30+ days ago Vertex Pharmaceuticals Inc discovers and develops small-molecule drugs for the treatment of serious diseases. Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. ET. Since 2012, more than 20,000 people have enrolled in Vertex GPS. Vertex Pharmaceuticals reported solid first-quarter results that outperformed FactSet consensus estimates on the top and bottom lines, driven by continued strong execution of … Vertex Pharmaceuticals is focused on developing treatments for cystic fibrosis (CF) and other life-threatening diseases. The Company is focused on developing and commercializing therapies for the treatment of cystic fibrosis (CF) and advancing its research and development programs in other indications. Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.It maintains headquarters in South Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, near Oxford, England Company Representatives. Vertex Pharmaceuticals Senior Scientist in the United States makes about $173,017 per year. Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. Job Description. a sub-category monopoly. VRTX 213.43 3.18 (1.47%). Average Vertex Pharmaceuticals hourly pay ranges from approximately $26.72 per hour for Clerical Worker to … The relationship between Vertex Pharmaceuticals (NASDAQ: VRTX) and CRISPR Therapeutics (NASDAQ: CRSP) is taking another big step forward. In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $215.01, marking a +0.87% move from the previous day. Find out where to park near Vertex Pharmaceuticals Inc. and book a space. Ionis is Vertex Pharmaceuticals Inc / Ma's #1 competitor. Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts. Vertex Pharmaceuticals' Earnings Growth And 31% ROE . P.O. Its key drugs are Kalydeco, … Vertex Pharmaceuticals Inc. analyst ratings, historical stock prices, earnings estimates & actuals. VRTX updated stock price target summary. Vertex GPS ™: Guidance & Patient Support. Vertex Pharmaceuticals Incorporated is engaged in discovering, developing, manufacturing and commercializing medicines for serious diseases. She was in the mood … Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) went down by -0.94% from its latest closing price compared to the recent 1-year high of $306.08. ";s:7:"keyword";s:22:"vertex pharmaceuticals";s:5:"links";s:1036:"<a href="http://digiprint.coding.al/site/trwzrk/military-to-get-covid-vaccine">Military To Get Covid Vaccine</a>,
<a href="http://digiprint.coding.al/site/trwzrk/kakaotalk-video-call-not-working">Kakaotalk Video Call Not Working</a>,
<a href="http://digiprint.coding.al/site/trwzrk/valentino-earrings-silver">Valentino Earrings Silver</a>,
<a href="http://digiprint.coding.al/site/trwzrk/homebody-sweatshirt-magnolia">Homebody Sweatshirt Magnolia</a>,
<a href="http://digiprint.coding.al/site/trwzrk/coldest-winter-in-history">Coldest Winter In History</a>,
<a href="http://digiprint.coding.al/site/trwzrk/optiver-salary-sydney">Optiver Salary Sydney</a>,
<a href="http://digiprint.coding.al/site/trwzrk/600-canadian-dollar-to-philippine-peso">600 Canadian Dollar To Philippine Peso</a>,
<a href="http://digiprint.coding.al/site/trwzrk/electron-ipc-send-from-main-to-renderer">Electron Ipc Send From Main To Renderer</a>,
<a href="http://digiprint.coding.al/site/trwzrk/snap-fitness-personal-trainer">Snap Fitness Personal Trainer</a>,
";s:7:"expired";i:-1;}

Zerion Mini Shell 1.0